IDiyas

For the Inventor, By the Inventor

Washingtonville, NY, United States of America

Lawrence W Torley

USPTO Granted Patents = 9

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 103(Granted Patents)


Location History:

  • Orange County, NY (US) (1989)
  • Washingtonville, NY (US) (1987 - 1992)

Company Filing History:

goldMedal9 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1987-1992

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5162328 - N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine (1992-11-10),
2. 4876252 - 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines (1989-10-24),
3. 4829089 - Substituted piperazine-1,4-naphthalenediones useful as anti-asthmatic (1989-05-09),
4. 4808586 - Substituted benzimidazoles and benzothidiazoles having anti-asthmatic (1989-02-28),
5. 4788195 - 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines (1988-11-29),
6. 4771061 - Substituted piperazine-1,4-naphthalenediones useful for treating asthma, (1988-09-13),
7. 4742059 - Substituted quinoxalinediones and their methods of use (1988-05-03),
8. 4692449 - Substituted quinolinediones (1987-09-08),
9. 4686220 - Substituted 2-[b-substituted-amino)-ethylamino]-1,4-naphthalenediones (1987-08-11),

Title: The Innovative Contributions of Lawrence W. Torley

Introduction

Lawrence W. Torley is a notable inventor based in Washingtonville, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of antiasthma agents. With a total of nine patents to his name, Torley's work has had a meaningful impact on the treatment of allergic diseases.

Latest Patents

Among his latest patents is the compound N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine, which is recognized for its pharmacologically acceptable salts. This compound is particularly useful as an antiasthma agent and in the treatment of allergic diseases, exhibiting improved bioavailability properties. Another significant patent involves 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines, which describes novel compounds that demonstrate antiasthmatic activity.

Career Highlights

Lawrence W. Torley is associated with the American Cyanamid Company, where he has been able to apply his innovative ideas and research. His work has contributed to advancements in pharmacological treatments, particularly in respiratory health.

Collaborations

Throughout his career, Torley has collaborated with notable colleagues, including Jeffrey B. Medwid and Andrew S. Tomcufcik. These collaborations have further enhanced the development of his patented inventions.

Conclusion

Lawrence W. Torley's contributions to the field of pharmacology through his innovative patents have made a significant impact on the treatment of asthma and allergic diseases. His work continues to influence the development of effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…